Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B

The immunogenicity and safety of a new recombinant hepatitis B vaccine from the Instituto Butantan (Butang®) were evaluated in a multicenter, double-blind, prospective equivalence study in three centers in Brazil. Engerix B® was the standard vaccine. A total of 3937 subjects were recruited and 2754...

Full description

Bibliographic Details
Published in:	Memorias do Instituto Oswaldo Cruz
Main Authors:	Reinaldo Menezes Martins, Gilberta Bensabath, Luiz Claudio Arraes, Maria de Lourdes Aguiar Oliveira, Juliana Custódio Miguel, Glayse Glayde Barbosa, Luiz Antonio Bastos Camacho
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 2004-12-01
Subjects:	hepatitis B vaccine recombinant vaccines immunization
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000800014

Similar Items

Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
by: Michael L. Landrum, et al.
Published: (2017-04-01)

Efficacy and Immunogenicity of Recombinant Pichinde Virus-Vectored Turkey Arthritis Reovirus Subunit Vaccine
by: Rahul Kumar, et al.
Published: (2022-03-01)

Safety and Immunogenicity of the Convacell<sup>®</sup> Recombinant N Protein COVID-19 Vaccine
by: Sevastyan Rabdano, et al.
Published: (2024-01-01)

Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression
by: Lorenzo Losa, et al.
Published: (2024-05-01)

Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus
by: Seo Young Moon, et al.
Published: (2024-08-01)

Recombinant vaccines and the development of new vaccine strategies
by: I.P. Nascimento, et al.
Published: (2012-12-01)

Immunogenic Evaluation of Bivalent Vaccine Candidate against Enterohemorrhagic and Enterotoxigenic Escherichia coli
by: Ahmad Karimi Rahjerdi, et al.
Published: (2019-09-01)

Impact of Molecular Modifications on the Immunogenicity and Efficacy of Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates in Mice
by: Carly M. Malavé, et al.
Published: (2021-12-01)

Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel
by: Ashley L. Fowlkes, et al.
Published: (2024-12-01)

Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
by: Antonia Radaelli, et al.
Published: (2024-11-01)

Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination
by: Baldy José Luís da Silveira, et al.
Published: (2004-01-01)

Algae-based oral recombinant vaccines
by: Elizabeth A Specht, et al.
Published: (2014-02-01)

Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines
by: Sonal Gupta, et al.
Published: (2023-09-01)

Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial
by: Eddy Fadlyana, et al.
Published: (2023-12-01)

Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
by: Tao Huang, et al.
Published: (2024-12-01)

Immunogenicity of a recombinant plant-produced respiratory syncytial virus F subunit vaccine in mice
by: Nuttapat Pisuttinusart, et al.
Published: (2024-03-01)

Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States
by: Ana Florea, et al.
Published: (2024-12-01)

Recombinant vaccines for COVID-19
by: Tushar Yadav, et al.
Published: (2020-12-01)

Production and Immunogenicity of a Tag-Free Recombinant Chimera Based on PfMSP-1 and PfMSP-3 Using Alhydrogel and Dipeptide-Based Hydrogels
by: Gaurav Anand, et al.
Published: (2021-07-01)

Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy
by: Domenico Ponticelli, et al.
Published: (2024-01-01)

Immunogenicity and protective efficacy of recombinant chimeric antigens based on surface proteins of Toxoplasma gondii
by: Maciej Chyb, et al.
Published: (2024-12-01)

Establishment of an in vivo potency assay for the recombinant hepatit is B surface antigen in monovalent and combined vaccines
by: Mabel Izquierdo-López, et al.
Published: (2014-12-01)

Recombination and Mutation in a New HP-PRRSV Strain (SD2020) from China
by: Yang Xia, et al.
Published: (2023-01-01)

Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
by: Richard K. Zimmerman, et al.
Published: (2023-01-01)

Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
by: Masoud Solaymani Dodaran, et al.
Published: (2023-02-01)

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study
by: Ravish H S, et al.
Published: (2021-11-01)

Novel Universal Recombinant Rotavirus A Vaccine Candidate: Evaluation of Immunological Properties
by: Dmitriy L. Granovskiy, et al.
Published: (2024-03-01)

Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes
by: Wang Ting, et al.
Published: (2017-01-01)

Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of <i>Mycobacterium tuberculosis</i> Sec Protein Export System
by: Annuurun Nisa, et al.
Published: (2022-06-01)

Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects
by: Ana Paula FERNANDES, et al.
Published: (1997-03-01)

Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses
by: Huimin Bai, et al.
Published: (2021-08-01)

Use of recombinant proteins for the diagnosis and prevention of Mycoplasma bovis: a systematic review
by: Camila Pachêco Gomes, et al.
Published: (2024-09-01)

Immunogenic Properties Studyoffusion Recombinant Proteins Based on VP6 and VP8 of Human Rotavirus A
by: I. V. Dukhovlinov, et al.
Published: (2015-04-01)

Lichen planus following recombinant zoster vaccine
by: Charli C. Gruen, 2d Lt, USAF, BS, et al.
Published: (2025-12-01)

The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018–2024
by: Yihao Li, et al.
Published: (2025-12-01)

Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialResearch in context
by: Joon Young Song, et al.
Published: (2023-10-01)

Recombination of Porcine Reproductive and Respiratory Syndrome Virus: Features, Possible Mechanisms, and Future Directions
by: Xing-Yang Cui, et al.
Published: (2024-06-01)

Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China
by: Jing Wang, et al.
Published: (2024-12-01)

Recombinant LSDV Strains in Asia: Vaccine Spillover or Natural Emergence?
by: Frank Vandenbussche, et al.
Published: (2022-06-01)

EFFECTS OF DIFFERENT ADJUVANTS UPON IMMUNOGENICITY OF ANTI-GROUP B STREPTOCOCCAL VACCINE COMPONENTS
by: A. N. Suvorov, et al.
Published: (2014-07-01)